NCT05183971

Brief Summary

Proprioceptive deficits in degenerative cervical myelopathy (DCM) is a progressive neurological deficits in somatosensory and motor function which affects the body balance and motor control. DCM usually presents with body incoordination, hand clumsiness and gait disturbance associated with proprioceptive dysfunction that hinders the physical performance and functions. In this study, a non-invasive assessment protocol on proprioception will be developed for detecting subtle proprioceptive deficits at the early stage of disease through simple Physical Performance Tests for population older than 45. By adopting the physical performance tests as the diagnostic predictors of DCM, we aim to avoid the development of devastating consequences and disabilities.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
126mo left

Started Sep 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress26%
Sep 2022Sep 2036

First Submitted

Initial submission to the registry

December 14, 2021

Completed
28 days until next milestone

First Posted

Study publicly available on registry

January 11, 2022

Completed
8 months until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
13.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2035

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2036

Last Updated

July 11, 2024

Status Verified

June 1, 2024

Enrollment Period

13.1 years

First QC Date

December 14, 2021

Last Update Submit

July 10, 2024

Conditions

Keywords

Degenerative Cervical MyelopathyProprioceptive Deficits

Outcome Measures

Primary Outcomes (1)

  • Modified Japanese Orthopaedics Association Scoring System for Cervical Myelopathy (mJOA)

    mJOA is a self-reported functional questionnaire on disease severity through assessing 4 domains: 1. Upper Limb Function 2. Lower Limb Function 3. Sensory Function 4. Bladder Function mJOA has a total score of 17 and it categories DCM patient into different severity as below: 1. Mild \>= 15 2. Moderate = 12-14 3. Severe \< 12

    15 years

Secondary Outcomes (2)

  • Proprioceptive Deficits - Speed Test

    15 years

  • Proprioceptive Deficits - Time Limited Test

    15 years

Study Arms (2)

(1) Degenerative Cervical Myelopathy

Chinese subjects aged 50 or above who have radiological evidence of Degenerative Cervical Myelopathy, symptomatic with Nurick Grade less than 3 will be included.

Other: Proprioceptive Functional Analysis System

(2) Healthy Controls

Chinese healthy controls aged 50 or above who have no myelopathic signs of Degenerative Cervical Myelopathy with Nurick Grade less than 3 will be included.

Other: Proprioceptive Functional Analysis System

Interventions

Proprioceptive testing and Physical Performance Tests

(1) Degenerative Cervical Myelopathy(2) Healthy Controls

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Radiologically confirmed with Degenerative Cervical Myelopathy

You may qualify if:

  • Chinese
  • Aged 50 or above
  • With radiological evidence of degenerative cervical myelopathy, both symptomatic and asymptomatic
  • Nurick grade less than 3

You may not qualify if:

  • Non-Chinese ethnicity
  • Aged under 50
  • without any radiological proof of cervical myelopathy
  • Active problems of tuberculosis spine, lumbar spinal diseases, and other problems causing pain or deformities over the limbs that may affect their balance and movement
  • Presents with extra-pyramidal or other disorders involving the cerebellum or frontal lobe of the cerebrum leading to poor balance and gait disturbance
  • Previous spinal operation with residual disturbance in balance or gait
  • Non-communicable patients with insufficient cognitive ability to express their symptoms clearly
  • Non-walker
  • Blind or deaf

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Duchess of Kent Children's Hospital at Sandy Bay

Hong Kong, 000, Hong Kong

RECRUITING

Study Officials

  • Karlen Ka Pui Law, M. Phil

    The University of Hong Kong

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Karlen Ka Pui Law, M. Phil

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 14, 2021

First Posted

January 11, 2022

Study Start

September 1, 2022

Primary Completion (Estimated)

September 30, 2035

Study Completion (Estimated)

September 30, 2036

Last Updated

July 11, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Data should not be shared with other researchers

Locations